2 résultats
Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer)
Auteurs / Authors
Bennouna J, Barlesi F, Do P, Dumont P, Cadranel J, Debieuvre D, Hilgers W, Molinier O, Quoix E, Raimbourg J, Langlais A, Morin F, Souquet P.J
Journal / Conference
ESMO open
Année / Year
2018
PMID / session
Etude IFCT
A phase II study assessing the benefit of cisplatin re-introduction (stop and go strategy) in patients with advanced non-squamous non-small cell lung cancer (NSCLC) : The IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer).
Auteurs / Authors
Fabrice Barlesi, Judith Raimbourg, Pascal Do, Patrick Dumont, Jacques Cadranel, Didier Debieuvre, Werner Hilgers, Pierre Jean Souquet, Olivier Molinier, Elisabeth A. Quoix, Alexandra Langlais, Marie Paule Lebitasy, Franck Morin, Gerard Zalcman, Jaafar Bennouna
Journal / Conference
ASCO
Année / Year
2016
PMID / session
Etude IFCT